top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
Autore Kim Jong Heon
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (282 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato 3-phenyl-1H-indazole
Acanthamoeba
Acanthamoeba keratitis
acetylsalicylic acid (ASA, aspirin)
all-trans retinoic acid
anticandidal activity
antifungal
antifungal drugs
antifungals
Aspergillus spp
azole
azoles
beta-glucan
biological synthesis
candida
Candida
candida albicans
Candida auris
Candida spp
candidosis
canesten
CAP64
capsule
cell integrity
cell lysis
cell separation
cell wall
clotrimazole
Cryptococcus
cyst
cytokinesis
dermatophytes
drug
drug delivery systems
drug design
drug discovery
drug repurposing
drug targets
echinocandin drugs
echinocandin resistance
echinocandins
emerging fungi
Felis catus
fission yeast
Fks resistance hot spots
free-living ameba
fungi
Galleria mellonella model
host-directed drug therapy
hydrazones
indazole
invasive aspergillosis treatment
invasive fungal infections
isavuconazonium sulfate
Malassezia spp
marine
membrane potential (ΔΨM)
microbiology
multidrug resistance
mycology
myconanotechnology
mycosis
n/a
nanoparticles
natural products
new targets
onychomycosis
photodynamic treatment
photosensitiser
polycations
polyenes
pyrazole
quinones
repositioning
resistance
retinoids
septation
sporotrichosis
synergy
therapeutic alternatives
ultrastructure
vaginal health
vaginitis
viral infections
vulvovaginal
yeast infection
yeasts
zoonoses
β(1,3)-D-glucan synthase
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Advances in Antifungal Development
Record Nr. UNINA-9910585935503321
Kim Jong Heon  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Computational and Experimental Approaches in Multi-Target Pharmacology
Computational and Experimental Approaches in Multi-Target Pharmacology
Autore Anastasio Thomas J
Pubbl/distr/stampa Frontiers Media SA, 2017
Descrizione fisica 1 online resource (122 p.)
Collana Frontiers Research Topics
Soggetto topico Pharmacology
Soggetto non controllato computer modeling
drug combination
drug discovery
drug repurposing
high throughput screening
multidrug therapeutics
multifactorial process
polypharmacy
synergy
systems biology
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910261143503321
Anastasio Thomas J  
Frontiers Media SA, 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Autore Tutone Marco
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (387 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato 3CL-Pro
3D-QSAR
acetylcholinesterase
aging progression mechanism
Alzheimer's disease
aminophenylbenzamide
antibody:antigen interactions
antivirals
binding free energies
binding site
binding space
carbon nanotubes
cholesterol
computational biology
consensus models
COVID-19
COX-2 inhibitors
deep learning
diabetes
docking simulations
doxorubicin encapsulation
drug delivery system
drug discovery
drug repositioning
drug repositioning approaches
drug repurposing
drug resistance
drug-resistance mutations
dual mode of action
dual-target lead discovery
epitope binning
epitope mapping
epitope prediction
FimH
fingerprints
gene expression signature
genome-wide genetic and epigenetic network (GWGEN)
glycoprotein D (gD)
haeckelite defects
HDACs
hERG toxicity
herpes simplex virus fusion proteins
high-throughput virtual screening
HIV-2 protease
homology modeling
hTSPO
human dihydrofolate reductase
immunoproteasome
in silico
induced structural deformations
induced-fit docking
inhibitors
isoform-selective histone deacetylase inhibitors
isomeric space
ligand-based model
machine learning
main protease
MD binding
MD simulation
metadynamics
methotrexate
molecular docking
molecular dynamics
molecular dynamics (MD) simulation
molecular dynamics simulation
molecular dynamics simulations
molecular modeling
MRP4
multi-modal
multiple-molecule drug
multiprotein inhibiting natural compounds
multiscale
multitargeting
mutants
Mycobacterium tuberculosis
n/a
natural compounds
neurodegenerative disorders
nicotinic acetylcholine receptor
non-covalent inhibitors
noncovalent interactions
oxidative stress
PF-00835231
pharmacophore model
pharmacophore modeling
PK11195
polypharmacology
proteasome
protein docking
protein threading modeling
proteomic signature
RNA expression regulation
SARS-CoV-2
skin aging
SNPs
sodium-glucose co-transporters 2
Src inhibitors
Stone-Wales defects
structural bioinformatics
structural characterization
systems medicine design
tuberculosis
urinary tract infections
uropathogenic bacteria
variants
virtual screening
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Computational Approaches
Record Nr. UNINA-9910557519403321
Tutone Marco  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Converging Nanochemistry: From Disease Prevention to Diagnosis and Treatment
Converging Nanochemistry: From Disease Prevention to Diagnosis and Treatment
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2023
Descrizione fisica 1 online resource (210 p.)
Soggetto topico Technology: general issues
Soggetto non controllato Andes virus
antibody
anticancer
antiproliferation
APN receptor
apoptosis
artificial intelligence
bacterial nanocellulose
biomarker particles
biopanning
cancer biomarker
CDR randomization
cell death
chemoprevention
colon cancer
colorectal cancer
conjugation strategy
controlled drug delivery system
covalent bonding
drug development
drug repurposing
early detection
electrochemical glycobiosensor
encapsulation
epidermal growth factor
fungal pathogens
genistein
glycan
in situ
infectious disease
inflammation
MEK inhibitors
miRNA
molecular docking
nanobody
nanomaterial
new therapeutic targets
non-covalent bonding
parasporin
phage display
protein modeling
protein structure
reactive oxygen species
site-directed mutagenesis
structural bioinformatics
styrylquinolines
surface modification
synthetic library
tumor necrosis factor
vascular endothelial growth factor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Converging Nanochemistry
Record Nr. UNINA-9910743276003321
MDPI - Multidisciplinary Digital Publishing Institute, 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
In Silico Strategies for Prospective Drug Repositionings
In Silico Strategies for Prospective Drug Repositionings
Autore Udrescu Lucreția
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (288 p.)
Soggetto topico Medicine
Pharmaceutical industries
Soggetto non controllato COVID-19
drug repurposing
topological data analysis
persistent Betti function
SARS-CoV-2
network-based pharmacology
combination therapy
nucleoside GS-441524
fluoxetine
synergy
antidepressant
natural compounds
QSAR
molecular docking
drug repositioning
UK Biobank
vaccine
LC-2/ad cell line
drug discovery
docking
MM-GBSA calculation
molecular dynamics
cytotoxicity assay
GWAS
multiple sclerosis
oxidative stress
repurposing
ADME-Tox
bioinformatics
complex network analysis
modularity clustering
ATC code
hidradenitis suppurativa
acne inversa
transcriptome
proteome
comorbid disorder
biomarker
signaling pathway
druggable gene
drug-repositioning
MEK inhibitor
MM/GBSA
Glide docking
MD simulation
MM/PBSA
single-cell RNA sequencing
pulmonary fibrosis
biological networks
p38α MAPK
allosteric inhibitors
in silico screening
computer-aided drug discovery
network analysis
psychiatric disorders
medications
psychiatry
mental disorders
toxoplasmosis
Toxoplasma gondii
in vitro screening
drug targets
drug-disease interaction
target-disease interaction
DPP4 inhibitors
lipid rafts
ISBN 3-0365-6133-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639987703321
Udrescu Lucreția  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Innovative Therapeutic and Vaccine Approaches against Respiratory Pathogens
Innovative Therapeutic and Vaccine Approaches against Respiratory Pathogens
Autore Chevalier Christophe
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 online resource (273 p.)
Soggetto topico Immunology
Medicine and Nursing
Soggetto non controllato adjuvant
antimicrobial peptide
drug repurposing
innovative delivery system
respiratory pathogen
therapeutics
vaccine
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557482503321
Chevalier Christophe  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Malignant Mesothelioma
Malignant Mesothelioma
Autore L. Pouliquen Daniel
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (328 p.)
Soggetto topico Medicine
Soggetto non controllato asbestos
asbestos exposure
BAP1
biomarkers
cancer biomarkers
cancer-specific mutations
cancers
carbon nanotubes
carcinogenesis
CDKN2A
circulating tumor DNA
dendritic cells
DNA damage response
DNA methylation
DNA sequencing
drug repurposing
epigenome-wide analysis
epithelioid
extrapleural pneumonectomy
fatty acid-binding protein
FDG
first line
gene expression
genomics
Hippo pathway
histotype
immune therapy
immunogenicity
immunohistochemistry
immunotherapy
infiltrating immune cells
inflammation
interaction analysis
laminin subunit beta-2
liquid biopsies
lurbinectedin
lymphocyte-to-monocyte ratio
macrophage-capping protein
malignant mesothelioma
malignant pleural mesothelioma
mesothelioma
mesothelium
meta-analysis
metabolomics
MPM
MTAP
mutation
n/a
network analysis
NF2
oxidative stress
PET-CT
plasma
pleural effusion
pleural mesothelioma
pleurectomy decortication
predictive biomarker
prognostic biomarker
protein-protein interactions
proteomics
PTCH1
radiotherapy
redox-sensitive factors
sarcomatoid
selenium-binding protein 1
SETD2
survival
survival analysis
systematic review
systems biology
targeted therapy
therapy response
tumor microenvironment
tumor suppressor
tumor-associated macrophages
VATS
WDPM
well-differentiated papillary mesothelioma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557359303321
L. Pouliquen Daniel  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer
Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer
Autore Nakayama Naomi
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (258 p.)
Soggetto topico Public health and preventive medicine
Soggetto non controllato adoptive immunotherapy
anti-angiogenic therapy
aryl hydrocarbon receptor
BEN (BANP, E5R and NAC1) domain
biological planning
biomarkers
borderline ovarian tumors
BRCA1 mutant ovarian cancer
cancer progression
CD44
cervical cancer
cervical neoplasia
chimeric antigen receptor
clear cell carcinoma
differentially expressed genes
DNA damage response
DNA mismatch repair (MMR)
drug repurposing
endometrial cancer
endometrial carcinoma
endometrioid endometrial cancer
epithelial ovarian cancer
epithelial ovarian cancers
epithelial-mesenchymal transition
exosome
gene ontology
gynecological cancer
HDR brachytherapy
human cytomegalovirus
immune checkpoints inhibitors
immune micro-environment
immunohistochemistry
immunosuppression
in vivo dosimetry
inflammation
integrative analysis
interventional radiotherapy
isothermal titration calorimetry (ITC)
liquid biopsy
long-term survival
melanoma treatment
microsatellite instability
miRNA
mismatch repair deficiency
MMR deficient (dMMR)
n/a
nanocarriers
NK cells
non-coding RNAs
nucleus accumbens-associated protein 1 (NAC1)
ovarian cancer
p16 protein
pGSK3β
PLA2G7)
platelet-activating factor acetylhydrolase (PAF-AH
prognosis
sequence-specific DNA-binding protein
solution NMR structure
somatic mutation
targeted therapy
testin
vaginal melanoma
vaginal-cuff brachytherapy
vulvar melanoma
Wnt signaling
β-catenin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580209103321
Nakayama Naomi  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
Autore Allison Simon J
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (206 p.)
Soggetto topico History of engineering & technology
Technology: general issues
Soggetto non controllato 5-FU resistance
8-hydroxydaidzein
affibody drug conjugate (AffiDC)
affibody molecule
albumin binding domain
angiogenesis
anti-cancer agent
anticancer drug
apoptosis
AQ4N
autophagy
B-lactam steroid alkylators
BCR-ABL
biomarker
bioprecursor
breast cancer
BxPC-3
c-myc
cancer hallmarks
CCN1
colorectal cancer
Connectivity Map
CYP1A1
CYP1B1
CYP2W1
Cytochrome P450
DM1
drug repurposing
duocarmycin
EGFR tyrosine kinase inhibitor
emtansine
expression
gene silencing
Genomics of Drug Sensitivity in Cancer
glioblastoma
HepG2
Huh7
human epidermal growth factor receptor 3 (HER3)
hybrid steroidal alkylating agents
in vivo imaging
invasion
isatin sulfonamides
K562
MAPK
mesenchymal-amoeboid transition
microtubule acetylation
migration
molecular docking
n/a
nanoparticles
nanosystems
NF-κB
oncogene
ovarian cancer
phortress
photon upconversion
PLGA
poly (ADP-ribose) polymerase inhibitors
prodrug
RNA interference
siRNA
synthetic lethality
triple-negative breast cancer
triplet-triplet annihilation
ISBN 3-0365-5222-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Novel Anti-cancer Agents and Cellular Targets and Their Mechanism
Record Nr. UNINA-9910619465503321
Allison Simon J  
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Treatment Strategies for Glioblastoma
Novel Treatment Strategies for Glioblastoma
Autore Stylli Stanley
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (268 p.)
Soggetto topico Medicine
Soggetto non controllato angiopoietin (Ang)
anti-angiogenesis
anticancer
brain cancer
brain tumor
cancer stem cell
cancer stem cell niche
cancer stem cells
cell cycle
chimeric antigen receptor (CAR) T cells
CK2
CRISPR/Cas9
CX-4945
de novo purine synthesis
differentiation
drug repurposing
drug targets
drug-inducible gene expression
endothelial nitric oxide synthase (eNOS)
GBM
gene therapy
glioblastoma
glioblastoma (GB)
glioblastoma multiforme
glioma
immune checkpoint inhibitors
immunotherapy
invadopodia
invasion
ion channels
Mardepodect
metabolic reprogramming
metabolic treatment
migration
n/a
nanomedicine
nerve/glial antigen 2
new trial design
newly diagnosed glioblastoma
NG2
novel therapy
one-carbon metabolism
organoids
P-bi-TAT
P-m-TAT
PEG
personalized treatment
pluripotent stem cells
proliferation
prolyl-oligopeptidase (POP)
radiotherapy
RAS
recurrent glioblastoma
Regorafenib
renin-angiotensin system
SRGAP2
stem cell
targeted therapy
temozolomide
tetrac
thyrointegrin αvβ3
TP53
transforming growth factor-β (TGF-β)
triazole tetrac
tumor antigens
tumor microenvironment
vaccine
vascular endothelial growth factor (VEGF)
viral vectors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557363703321
Stylli Stanley  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui